Our therapy areas
Unlocking the power of what science can do
The path to new treatments
The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Cardiovascular, Renal and Metabolism; Oncology; Respiratory, Inflammation and Autoimmunity; Infection and Vaccines; and Neuroscience.
Oncology
Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer.
Cardiovascular, Renal and Metabolism
CVRM (Cardiovascular, Renal and Metabolism) is one of our main therapy areas because science continues to uncover commonalities between metabolism, heart failure, arterial vascular disease and renal disease – four distinct but interrelated areas.
Entering a new era in vascular and cardiac regeneration research
As we move novel therapeutic modalities from the laboratory into clinical trials, we are focusing on the repair and regeneration of tissues with the potential to treat life threatening cardiovascular diseases such as heart failure.
Read the full story
Respiratory & Immunology
We are entering an era of unprecedented potential to deliver scientific breakthroughs within asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and chronic cough.
Other disease areas
We have medicines and vaccines in other disease areas that have an important impact for patients. As such, we are selectively active in the areas of autoimmunity, infection & vaccines, neuroscience and gastroenterology, where we follow an opportunity-driven approach and often work through partnerships.
An exciting pipeline
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.
177
projects in our pipeline
15
new molecular entities in our late-stage pipeline
2
new molecular entity approvals
What science can do
Our purpose is to push the boundaries of science to deliver life-changing medicines